Immunovant, Inc.

	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Dec-18	Mar-18
Total revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross profit	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total operating expenses +	0.53	0.44	0.27	0.21	0.16	0.11	0.06	0.00		0.14
Selling, general and administrative	0.08	0.08	0.06	0.05	0.05	0.04	0.02	0.00		0.00
Research and development	0.46	0.36	0.21	0.16	0.10	0.07	0.05	0.03		0.14
Other operating expenses	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.03	0.00	0.00
Operating income	-0.53	-0.44	-0.27	-0.21	-0.16	-0.11	-0.06	0.00	0.00	-0.14
Non-operating income (net)	0.03	0.03	0.01	0.00	0.00	0.00	-0.01	0.00	0.00	0.00
Income before tax	-0.51	-0.41	-0.26	-0.21	-0.16	-0.11	-0.07	0.00	0.00	-0.14
Income tax expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net income	-0.51	-0.41	-0.26	-0.21	-0.16	-0.11	-0.07	0.00	0.00	-0.14

Show Quarterly Income Statement

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18
Total revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of revenue		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00				0.00		0.00	0.00
Gross profit		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00				0.00		0.00	0.00
Total operating expenses +	0.16	0.11	0.13	0.13	0.11	0.11	0.12	0.09	0.08	0.06	0.06	0.07	0.06	0.05	0.05	0.04	0.05	0.04	0.04	0.03	0.03	0.03	0.02	0.03	0.02	0.01	0.00	0.00	0.00	0.01	0.01	0.00
Selling, general and administrative	0.02	0.02	0.02	0.03	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.02	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Research and development	0.14	0.10	0.11	0.10	0.09	0.09	0.10	0.08	0.07	0.05	0.05	0.05	0.05	0.04	0.04	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.01	0.02	0.01	0.00	0.01	0.02	0.01	0.01	0.01	0.00
Other operating expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.02	-0.01	0.00	0.00	0.00
Operating income	-0.16	-0.11	-0.13	-0.13	-0.11	-0.11	-0.12	-0.09	-0.08	-0.06	-0.06	-0.07	-0.06	-0.05	-0.05	-0.04	-0.05	-0.04	-0.04	-0.03	-0.03	-0.03	-0.02	-0.03	-0.02	-0.01	0.00	0.00	0.00	-0.01	-0.01	0.00
Non-operating income (net)	0.01	0.01	0.01	0.01	0.01	0.00	0.01	0.01	0.01	0.01	0.00	-0.01	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income before tax	-0.15	-0.11	-0.13	-0.12	-0.11	-0.11	-0.11	-0.09	-0.08	-0.05	-0.06	-0.07	-0.06	-0.06	-0.05	-0.04	-0.05	-0.04	-0.04	-0.03	-0.03	-0.03	-0.02	-0.03	-0.02	-0.01	0.00	0.00	0.00	-0.01	-0.01	0.00
Income tax expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net income	-0.15	-0.11	-0.13	-0.12	-0.11	-0.11	-0.11	-0.09	-0.08	-0.05	-0.06	-0.07	-0.06	-0.06	-0.05	-0.04	-0.05	-0.04	-0.04	-0.03	-0.03	-0.03	-0.02	-0.03	-0.02	-0.01	0.00	0.00	0.00	-0.01	-0.01	0.00

1 day ago

Ask a follow up

	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Total cash and short-term investments +	0.90	0.71	0.64	0.38	0.49	0.40	0.10	0.00	0.00
Cash and cash equivalents	0.90	0.71	0.64	0.38	0.49	0.40	0.10	0.00
Short-term investments
Accounts receivable, net	0.00	0.00	0.01	0.00	0.01	0.00	0.00	0.00
Inventories			-0.02	0.00	0.00	0.00
Other current assets	0.04	0.05	0.02	0.03	0.01	0.01	0.01	0.00	0.00
Total current assets	0.95	0.77	0.67	0.40	0.51	0.41	0.11	0.00	0.00
Total non-current assets +	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Property, plant and equipment, net				0.00	0.00	0.00	0.00	0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.96	0.78	0.67	0.41	0.52	0.41	0.11	0.00	0.00

Total current liabilities +	0.10	0.07	0.05	0.04	0.04	0.02	0.02	0.00	0.00
Accounts payable	0.01	0.02	0.01	0.00	0.02	0.00	0.00	0.00	0.00
Short-term debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current portion of long-term debt								0.00
Deferred revenue
Other current liabilities	0.10	0.05	0.04	0.04	0.02	0.02	0.01	0.00	0.00
Total non-current liabilities +	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Long-term debt
Capital lease obligations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other non-current liabilities				0.00	0.00	0.00
Total liabilities	0.10	0.07	0.05	0.04	0.05	0.02	0.02	0.00	0.00

Total stockholders' equity +	0.85	0.71	0.62	0.36	0.47	0.39	0.09	0.00	0.00
Common stock and paid-in capital	2.60	1.95	1.44	0.93	0.83	0.59	0.19	0.00	0.00
Retained earnings	-1.75	-1.24	-0.83	-0.57	-0.36	-0.20	-0.09	0.00
Common shares outstanding	182	152	138	123	110	88	43	14	10

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18
Total cash and short-term investments +	0.90	0.99	0.52	0.60	0.71	0.37	0.47	0.56	0.64	0.69	0.27	0.33	0.38	0.43	0.41	0.43	0.49	0.53	0.56	0.38	0.40	0.42	0.44	0.28	0.10	0.12	0.12	0.12	0.00	0.00	0.00	0.00
Cash and cash equivalents	0.90	0.99	0.52	0.60	0.71	0.37	0.47	0.56	0.64	0.69	0.27	0.33	0.38	0.43	0.41	0.43	0.49	0.53	0.56	0.38	0.40	0.42	0.44	0.28	0.10	0.12	0.00	0.00	0.00
Short-term investments																											0.12	0.12
Accounts receivable, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventories										0.00			0.00				0.00				0.00
Other current assets	0.04	0.05	0.05	0.05	0.05	0.04	0.03	0.03	0.02	0.02	0.02	0.02	0.03	0.02	0.02	0.02	0.01	0.01	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Total current assets	0.95	1.04	0.57	0.65	0.77	0.41	0.51	0.59	0.67	0.71	0.29	0.35	0.40	0.45	0.43	0.46	0.51	0.54	0.56	0.38	0.41	0.43	0.45	0.29	0.11	0.13	0.00	0.00	0.00
Total non-current assets +	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.12	0.00
Property, plant and equipment, net												0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.96	1.05	0.58	0.66	0.78	0.42	0.52	0.59	0.67	0.71	0.29	0.35	0.41	0.46	0.43	0.46	0.52	0.54	0.57	0.39	0.41	0.43	0.45	0.29	0.11	0.13	0.12	0.12	0.00

Total current liabilities +	0.10	0.07	0.06	0.05	0.07	0.07	0.07	0.05	0.05	0.03	0.04	0.05	0.04	0.04	0.03	0.02	0.04	0.04	0.03	0.02	0.02	0.02	0.01	0.02	0.02	0.01	0.00	0.00	0.00
Accounts payable	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.01	0.01	0.00	0.01	0.03	0.00	0.01	0.01	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Short-term debt	0.00				0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00	0.00
Current portion of long-term debt																													0.00
Deferred revenue
Other current liabilities	0.10	0.06	0.06	0.05	0.05	0.05	0.05	0.03	0.04	0.03	0.03	0.02	0.04	0.03	0.02	0.02	0.02	0.03	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Total non-current liabilities +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00			0.00
Long-term debt
Capital lease obligations	0.00				0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other non-current liabilities													0.00				0.00			0.00	0.00
Total liabilities	0.10	0.07	0.06	0.05	0.07	0.07	0.07	0.05	0.05	0.03	0.04	0.05	0.04	0.04	0.03	0.02	0.05	0.04	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.00	0.00	0.00			0.00

Total stockholders' equity +	0.85	0.99	0.52	0.61	0.71	0.35	0.45	0.54	0.62	0.68	0.25	0.30	0.36	0.41	0.40	0.44	0.47	0.51	0.54	0.37	0.39	0.41	0.44	0.27	0.09	0.11	0.11	0.11	0.00			0.00
Common stock and paid-in capital	2.60	2.58	2.01	1.97	1.95	1.49	1.47	1.46	1.44	1.43	0.95	0.94	0.93	0.92	0.84	0.83	0.83	0.81	0.80	0.59	0.59	0.58	0.58	0.39	0.19	0.18	0.11	0.11	0.00	0.00	0.00	0.00
Retained earnings	-1.75	-1.60	-1.49	-1.36	-1.24	-1.13	-1.02	-0.91	-0.83	-0.75	-0.70	-0.64	-0.57	-0.51	-0.44	-0.40	-0.36	-0.31	-0.27	-0.23	-0.20	-0.17	-0.14	-0.12	-0.09	-0.07	0.00	0.00	0.00
Common shares outstanding	204	182	174	171	152	147	146	146	145	145	131	131	130	129	117	117	116	115	109	98	98	98	98	84	71	41	41	3	3	37	18	10

1 day ago

Ask a follow up

	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Dec-18	Mar-18
Operating cash flow +	-0.41	-0.38	-0.21	-0.19	-0.11	-0.08	-0.05	-0.03		-0.13
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00
Stock-based compensation	0.06	0.05	0.04	0.03	0.03	0.02	0.01	0.00		0.00
Change in inventory						0.00	0.00
Other working capital changes	-0.46	-0.43	-0.26	-0.22	-0.14	-0.10	-0.06	-0.03	0.00	-0.13
Cash flow from investing +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash flow from financing +	0.60	0.45	0.47	0.07	0.20	0.38	0.15	0.04	0.00	0.13
Dividend payout
Common stock repurchases				0.07	0.20	0.39	0.00	0.00	0.00
Net Debt Issuance	0.60	0.45	0.47	0.00	0.00	0.00	0.15	0.04	0.00	0.13

Change in cash	0.19	0.08	0.26	-0.12	0.09	0.30	0.09	0.01	0.00	0.00

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18
Operating cash flow +	-0.10	-0.09	-0.10	-0.12	-0.11	-0.10	-0.09	-0.08	-0.06	-0.05	-0.06	-0.05	-0.06	-0.05	-0.02	-0.07	-0.03	-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	-0.01	-0.02	0.00	0.00	0.00	0.00	-0.01	0.00	-0.01
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in inventory																	0.01
Other working capital changes	-0.11	-0.11	-0.12	-0.14	-0.12	-0.11	-0.10	-0.09	-0.07	-0.06	-0.06	-0.05	-0.06	-0.05	-0.03	-0.07	-0.06	-0.04	-0.03	-0.03	-0.03	-0.03	-0.03	-0.02	-0.02	0.00	0.00	0.00	0.00	-0.01	0.00	-0.01
Cash flow from investing +	0.00				0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash flow from financing +	0.00	0.56	0.02	0.00	0.45	0.00	0.00	0.00	0.00	0.47	0.00	0.00	0.00	0.07	0.07	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.19	0.19	0.00	0.00	0.00	0.12	-0.18	0.01	0.01	0.01
Dividend payout
Common stock repurchases												0.00	0.00	0.07		0.00			0.20						0.00	-0.12	0.12	0.12
Net Debt Issuance	0.00	0.56	0.02	0.00	0.45	0.00	0.00	0.00	0.00	0.47	0.00	0.00	0.00	0.00	0.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.19	0.00	0.12	-0.12	0.00	-0.18	0.01	0.01	0.01

Change in cash	-0.09	0.47	-0.08	-0.11	0.34	-0.10	-0.09	-0.08	-0.06	0.42	-0.06	-0.05	-0.06	0.02	0.05	-0.07	-0.03	-0.03	0.18	-0.02	-0.02	-0.02	0.16	0.18	-0.02	0.00	0.00	0.12	-0.18	0.01	0.01	0.00

1 day ago

Ask a follow up

Immunovant, Inc.

Income Statement - Immunovant, Inc. (IMVT)

Income Statement - Immunovant, Inc. (IMVT)

Balance Sheet - Immunovant, Inc. (IMVT)

Balance Sheet - Immunovant, Inc. (IMVT)

Cash Flow - Immunovant, Inc. (IMVT)

Cash Flow - Immunovant, Inc. (IMVT)